Benotti69 said:
King Boonen said:
Benotti69 said:
yaco said:
it's a non story. Of course no one wishes to discuss the most important issue. That all AAFS are supposed to remain private. It's a disgrace that British Cycling has leaked this information to divert attention from their internal issues. A rubbish organisation.
Cyclist who doesn't have asthma is caught taking a
non common asthma medication without TUE is a non story!
Really? This is a big story so much so the Guardian has an article on levels of so called asthmatics in sport.
The idea the Yates is only on Terbutaline and this is not part of a cocktail of PEDS is also funny.
Link? Or is this just made up?
Orica Greenedge, Simon Yates team, in their statement called it a 'new drug'. Not in use in USA.
Orica Greened are going with inhaler story but Terbutaline, is normally injected or taken orally.
But they could've just made that up!
Here is Orica Greenedge's statement, direct from their website:
"Statement regarding Simon Yates’ adverse analytical finding
On April 22, the team was notified that Simon Yates has an adverse analytical finding from a test conducted at Paris-Nice, stage 6 on March 12, 2016.
The positive result is for the substance Terbutaline.
The substance was given to Simon Yates in the form an asthma inhaler and accordingly, this was noted by the team doctor on the Doping Control Form, signed at the time of the test.
The substance was given in an ongoing treatment of Simon Yates’ documented asthma problems. However, in this case the team doctor made an administrative error by failing to apply for the TUE required for the use of this treatment.
The use of Terbutaline without a current TUE is the reason it has been flagged as an adverse analytical finding. This is solely based on a human error that the doctor in question has taken full responsibility for.
There has been no wrong-doing on Simon Yates’ part. The team takes full responsibility for this mistake and wishes to underline their support for Simon during this process.
The team is concerned by the leak of this information and has no further comments until there has been a full evaluation made of the documentation, statements and evidence that the team and Simon Yates are now submitting to the UCI in order to clarify everything."
Could you underline the word new for me please. Or even point out where they call it a "new drug"?
It is not a new drug, I can find clinical comparison papers from 1970.
Do you have a link to show it is normally injected of in tablet form? Because again, I can find papers from 1970 talking about inhaled terbutaline.
Or... You could have just made that all up?